Is It Time to Sell Teva Pharmaceutical's Stock?

Teva Pharmaceutical (NYSE: TEVA  ) is a selection for the real-money Inflation-Protected Income Growth portfolio. Like any investment, it needs to be reviewed from time to time to see whether it still deserves a spot in the portfolio. In the brief following video, portfolio manager Chuck Saletta reviews its valuation, balance sheet, and dividends and decides whether to hold on to the stock or let it go.

To follow the IPIG portfolio as buy and sell decisions are made, watch Chuck's article feed by clicking here. To join The Motley Fool's free discussion board dedicated to the IPIG portfolio, simply click here.

Investing doesn't have to be rocket science -- even if you're buying companies that make rockets
Millions of Americans have waited on the sidelines since the market meltdown in 2008 and 2009, too scared to invest and put their money at further risk. Yet those who've stayed out of the market have missed out on huge gains and put their financial futures in jeopardy. In our brand-new special report, "Your Essential Guide to Start Investing Today," The Motley Fool's personal finance experts show you why investing is so important and what you need to do to get started. Click here to get your copy today -- it's absolutely free.


Read/Post Comments (1) | Recommend This Article (7)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

  • Report this Comment On August 20, 2013, at 12:00 PM, mrconnors0531 wrote:

    If you want to leave teva you should check out the newest Israel bio tech cgen a two bagger in a month and only beginning. Read about their ability to help out in the fight against a

    lot of major illness by computer DNA sequence.

    Is it the next Tesla or Netflix? What is a $9 stock worth if they have a $500 m dream come true with only 35m outstanding shares. Can you think about chart over ten years that could look like apples $5 to $700 maybe.

Add your comment.

DocumentId: 2601323, ~/Articles/ArticleHandler.aspx, 4/21/2014 12:43:16 AM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...


Advertisement